News and Press Releases

CARBOGEN AMCIS Announces Successful Refinancing and Enhancement of their Syndicated Credit Facilities to Support Continued Growth and Investment

12 November 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a subsidiary of Dishman Carbogen Amcis, and a global top-tier Contract Development and Manufacturing Organisation (CDMO), today announced the successful refinancing and...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: November 12, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform

7 October 2025 -- Basel, Switzerland -- CELONIC GROUP, one of the leading “pureplay” Biologics CDMO, and the Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API)...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 7, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

CARBOGEN AMCIS Accelerates Manufacturing Capacity with CHF 25.5 Million Co-Investment at Swiss Sites

4 June 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce a strategic co-investment of more...

Category: Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 4, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA

22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: April 22, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

CARBOGEN AMCIS Announces Leadership Transition

3 February 2025 – Bubendorf, Switzerland –Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal...

Category:
Posted: February 3, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

January 13 2025 – Bubendorf, Switzerland — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...

Category: Pharmaceutical
Posted: January 16, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

13 January 2025 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 13, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

CARBOGEN AMCIS Announces Two Successful FDA Inspections at its Manufacturing Sites in Neuland and Aarau, Switzerland

23 July 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...

Category: BioManufacturing, Other, Pharmaceutical
Posted: July 23, 2024

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China

19 March 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory...

Category: BioManufacturing
Posted: March 19, 2024

Hauptstrasse 171 CH-4416 Bubendorf Switzerland